Ibogaine, an alkaloid from the Tabernanthe iboga plant, reduces withdrawal symptoms in animal models of drug addiction, and its effects outlast its presence in the body, suggesting lasting metabolic changes. In rats given a single 20 mg/kg dose, brain protein analysis at 24 and 72 hours revealed increased levels of key energy-metabolism enzymes: glyceraldehyde-3-phosphate dehydrogenase, aldolase A, pyruvate kinase, and malate dehydrogenase. These enzymes are involved in glycolysis and the tricarboxylic acid cycle. The findings indicate that ibogaine's anti-addiction effects may arise from enhanced energy availability, supporting cellular changes needed for detoxification and reversal of drug tolerance.
Ibogaine, known for its anti-addictive effects, alters energy metabolism in a way that is not species- or tissue-specific. In yeast (Saccharomyces cerevisiae) grown with 1 mg/l ibogaine for 5 hours, enzymes involved in energy production—glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate kinase, enolase, and alcohol dehydrogenase—were induced. This induction compensates for a drop in ATP levels observed after ibogaine exposure. The effect occurs without involvement of receptors, which are absent in yeast, indicating a direct metabolic influence rather than receptor-mediated action.